News & Events
Latest
Introducing new professional development programming for Biostatistics students, led by Maggie Tarnawa.
University of Washington researchers Sharon Browning and Seth Temple co-authored a study proposing new statistical methods for detecting signatures of strong natural selection that have occurred in humans in the past several thousand years.
Kendrick Li, PhD returned to UW as a guest presenter at the UW Biostatistics autumn seminar. Li graduated from the UW Biostatistics PhD program in 2021 and, after a postdoc at the University of Michigan, joined the faculty at St. Jude Children’s Research Hospital. Read our interview with Li.
Longer-term data from SWOG S1826 trial confirm nivolumab-AVD benefit in Hodgkin lymphoma
SWOG Cancer Research Network,
Two years after starting treatment, patients with stage 3-4 classic Hodgkin lymphoma treated with nivolumab plus AVD chemotherapy had roughly one-half the risk of progression or death of those who had a standard treatment of brentuximab vedotin plus AVD.
“This new analysis with more patient follow-up is critical to understanding the clinically meaningful benefit obtained from N-AVD compared to BV-AVD,” said Michael LeBlanc, PhD, lead biostatistician on the S1826 study and a UW professor of biostatistics.
Service available beginning October 2 for PhD applicants